ATC code A10
| ATC code A: Alimentary tract and metabolism |
|---|
|
| Other ATC codes |
ATC code A10 Drugs used in diabetes is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup A10 is part of the anatomical group A Alimentary tract and metabolism.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QA10.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
A10A Insulins and analogues[edit]
A10AB Insulins and analogues for injection, fast-acting[edit]
- A10AB01 Insulin (human)
- A10AB02 Insulin (beef)
- A10AB03 Insulin (pork)
- A10AB04 Insulin lispro
- A10AB05 Insulin aspart
- A10AB06 Insulin glulisine
- A10AB30 Combinations
A10AC Insulins and analogues for injection, intermediate-acting[edit]
- A10AC01 Insulin (human)
- A10AC02 Insulin (beef)
- A10AC03 Insulin (pork)
- A10AC04 Insulin lispro
- A10AC30 Combinations
A10AD Insulins and analogues for injection, intermediate- or long-acting combined with fast-acting[edit]
- A10AD01 Insulin (human)
- A10AD02 Insulin (beef)
- A10AD03 Insulin (pork)
- A10AD04 Insulin lispro
- A10AD05 Insulin aspart
- A10AD06 Insulin degludec and insulin aspart
- A10AD30 Combinations
A10AE Insulins and analogues for injection, long-acting[edit]
- A10AE01 Insulin (human)
- A10AE02 Insulin (beef)
- A10AE03 Insulin (pork)
- A10AE04 Insulin glargine
- A10AE05 Insulin detemir
- A10AE06 Insulin degludec
- A10AE07 Insulin icodec
- A10AE30 Combinations
- A10AE54 Insulin glargine and lixisenatide
- A10AE56 Insulin degludec and liraglutide
A10AF Insulins and analogues for inhalation[edit]
- A10AF01 Insulin (human)
A10B Blood glucose lowering drugs, excluding insulins[edit]
A10BA Biguanides[edit]
- A10BA01 Phenformin
- A10BA02 Metformin
- A10BA03 Buformin
A10BB Sulfonylureas[edit]
- A10BB01 Glibenclamide
- A10BB02 Chlorpropamide
- A10BB03 Tolbutamide
- A10BB04 Glibornuride
- A10BB05 Tolazamide
- A10BB06 Carbutamide
- A10BB07 Glipizide
- A10BB08 Gliquidone
- A10BB09 Gliclazide
- A10BB10 Metahexamide
- A10BB11 Glisoxepide
- A10BB12 Glimepiride
- A10BB31 Acetohexamide
A10BC Sulfonamides (heterocyclic)[edit]
- A10BC01 Glymidine
A10BD Combinations of oral blood glucose lowering drugs[edit]
- A10BD01 Phenformin and sulfonylureas
- A10BD02 Metformin and sulfonylureas
- A10BD03 Metformin and rosiglitazone
- A10BD04 Glimepiride and rosiglitazone
- A10BD05 Metformin and pioglitazone
- A10BD06 Glimepiride and pioglitazone
- A10BD07 Metformin and sitagliptin
- A10BD08 Metformin and vildagliptin
- A10BD09 Pioglitazone and alogliptin
- A10BD10 Metformin and saxagliptin
- A10BD11 Metformin and linagliptin
- A10BD12 Pioglitazone and sitagliptin
- A10BD13 Metformin and alogliptin
- A10BD14 Metformin and repaglinide
- A10BD15 Metformin and dapagliflozin
- A10BD16 Metformin and canagliflozin
- A10BD17 Metformin and acarbose
- A10BD18 Metformin and gemigliptin
- A10BD19 Linagliptin and empagliflozin
- A10BD20 Metformin and empagliflozin
- A10BD21 Saxagliptin and dapagliflozin
- A10BD22 Metformin and evogliptin
- A10BD23 Metformin and ertugliflozin
- A10BD24 Sitagliptin and ertugliflozin
- A10BD25 Metformin, saxagliptin and dapagliflozin
- A10BD26 Metformin and lobeglitazone
- A10BD27 Metformin, linagliptin and empagliflozin
- A10BD28 Metformin and teneligliptin
- A10BD29 Sitagliptin and dapagliflozin
A10BF Alpha glucosidase inhibitors[edit]
A10BG Thiazolidinediones[edit]
- A10BG01 Troglitazone
- A10BG02 Rosiglitazone
- A10BG03 Pioglitazone
- A10BG04 Lobeglitazone
A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors[edit]
- A10BH01 Sitagliptin
- A10BH02 Vildagliptin
- A10BH03 Saxagliptin
- A10BH04 Alogliptin
- A10BH05 Linagliptin
- A10BH06 Gemigliptin
- A10BH07 Evogliptin
- A10BH08 Teneligliptin
- A10BH51 Sitagliptin and simvastatin
- A10BH52 Gemigliptin and rosuvastatin
A10BJ Glucagon-like peptide-1 (GLP-1) analogues[edit]
- A10BJ01 Exenatide
- A10BJ02 Liraglutide
- A10BJ03 Lixisenatide
- A10BJ04 Albiglutide
- A10BJ05 Dulaglutide
- A10BJ06 Semaglutide
- A10BJ07 Beinaglutide
A10BK Sodium-glucose co-transporter 2 (SGLT2) inhibitors[edit]
- A10BK01 Dapagliflozin
- A10BK02 Canagliflozin
- A10BK03 Empagliflozin
- A10BK04 Ertugliflozin
- A10BK05 Ipragliflozin
- A10BK06 Sotagliflozin
- A10BK07 Luseogliflozin
- A10BK08 Bexagliflozin
- QA10BK90 Velagliflozin
A10BX Other blood glucose lowering drugs, excluding insulins[edit]
- A10BX01 Guar gum
- A10BX02 Repaglinide
- A10BX03 Nateglinide
- A10BX05 Pramlintide
- A10BX06 Benfluorex
- A10BX08 Mitiglinide
- A10BX15 Imeglimin
- A10BX16 Tirzepatide
- A10BX17 Carfloglitazar
- A10BX18 Dorzagliatin
A10X Other drugs used in diabetes[edit]
A10XA Aldose reductase inhibitors[edit]
- A10XA01 Tolrestat
AA10XX Other drugs used in diabetes[edit]
- A10XX01 Teplizumab
References[edit]
- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code A10". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QA10". WHO Collaborating Centre for Drug Statistics Methodology.